Preliminary Study on Eye Features of Patients With Malignant Tumors

CompletedOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

September 20, 2022

Study Completion Date

September 20, 2022

Conditions

Feature ElongationCancer Patients

Trial Locations (1)

Yichen Dr. Xu, Beijing

All Listed Sponsors

lead

Peking University Cancer Hospital & Institute

OTHER

NCT04224298 - Preliminary Study on Eye Features of Patients With Malignant Tumors | Biotech Hunter | Biotech Hunter